i think price will continue to trend down to where i indicated.
in this Current BTC market we have a bunch of Liquidity sitting at 95k and 90k so we will most likely get these this week Source: Liquidity Heatmap
1000SATS/USDT: Poised for a Breakout from Middle Support 1000SATS/USDT is showing promising signs ? as it holds firmly at a key middle support zone ?. The pair is building momentum, creating an ideal setup for a potential breakout ?. If confirmed, this move could trigger a strong bullish rally ?. Stay vigilant ? and wait for the breakout confirmation before entering. Key insights: 1. Middle support: 1000SATS/USDT is holding steady at this critical zone, showing resilience against further downside. 2. Volume watch: A significant surge in trading volume during the breakout will confirm the buyers’ strength ?. 3. Bullish indicators: Positive trends in RSI and MACD ⚡ support the likelihood of an upward breakout. Steps to confirm the breakout: Wait for a clear 4H or daily candle to close above the resistance level ?. Look for a noticeable volume spike, signaling strong buying interest ?. A successful retest of the resistance-turned-support will solidify the move ✅. Be cautious of fakeouts, such as quick reversals or wicks ⚠️. Risk management strategies: Use stop-loss orders to protect your position ?. Align position sizing with your overall risk strategy ?. This analysis is for educational purposes only and not financial advice. Always DYOR ? before making any trading decisions.
Hey Traders, in today's trading session we are monitoring US30 for a buying opportunity around 44350 zone, US30 is trading in an uptrend and currently is in a correction phase in which it is approaching the trend at 44350 support and resistance area. Trade safe, Joe.
Company Overview: Wave Life Sciences NASDAQ:WVE is a pioneer in RNA-targeted therapies, focusing on rare genetic diseases and conditions with significant unmet medical needs. Key Growth Catalysts: Breakthrough in RNA Editing ? WVE-006: Demonstrates the first-ever in-human evidence of RNA editing, a historic milestone for RNA medicine. This platform unlocks new opportunities to treat genetic diseases with precision, differentiating Wave from peers. Expanding Obesity Market Opportunity ? WVE-007: A promising GalNAc-siRNA therapy targeting INHBE, addressing the multi-billion-dollar obesity market. Clinical trials begin in Q1 2025, offering a potential blockbuster treatment for obesity—a market in high demand. Duchenne Muscular Dystrophy (DMD) ? WVE-N531: Positive interim data highlights its potential to secure accelerated approval, providing new hope for DMD patients. Innovative Pipeline & Chemistry ? Wave’s PRISM platform and advanced stereopure chemistry give it a competitive edge in RNA therapeutics. A robust pipeline targeting various high-value indications reinforces long-term growth prospects. Investment Outlook: Bullish Stance: We are bullish on WVE above $12.50-$13.00, driven by groundbreaking RNA editing advancements, an expanding obesity opportunity, and promising DMD data. Upside Target: Our price target is $24.00-$25.00, reflecting transformative potential across multiple programs and significant upside in addressing major unmet medical needs. ? Wave Life Sciences—Unlocking the Power of RNA Medicine! #WVE #RNAEditing #Biotech #Innovation
Gold finally broke the range, looking for a buy setup on a lower time frame. Remember to partially book profit after 50-70 pips, and SL will be on BE after 50 pips.
Current bar looks prominent, rising above all EMAs, rally may start once silver crosses 32.9, lets wait and watch!
AUDCHF trend is bearish price making LH TO LL my at current resistance level RRR 1:1
Company Overview: TSMC NYSE:TSM is the world's leading semiconductor foundry, driving innovation in advanced chip manufacturing for critical technologies like AI, 5G, and emerging tech markets. Key Growth Catalysts: Strategic U.S. Expansion ?? Arizona Fab: TSMC’s first 12-inch wafer fab begins 4 nm chip production this month, solidifying its North American presence. $40 Billion Investment: Demonstrates TSMC's long-term confidence in U.S. chip demand and geopolitical supply chain security. Production of 3 nm chips by 2028 highlights TSMC’s roadmap for next-gen leadership. Rising Global Chip Demand ? Surging demand from AI, 5G, and cloud computing is driving industry-wide growth. Key Clients: Apple, Nvidia, and AMD rely heavily on TSMC’s advanced node production capabilities. Technological Leadership ? 4 nm Mass Production (Q1 2025): Positions TSMC at the forefront of advanced node production. Continued R&D investments strengthen TSMC’s competitive edge in next-gen chip technologies. Investment Outlook: Bullish Stance: We are bullish on TSM above $172.00-$174.00, underpinned by its global dominance, strategic U.S. investments, and demand for advanced nodes. Upside Target: Our price target is $255.00-$260.00, reflecting robust revenue growth, margin expansion, and rising semiconductor demand in AI and 5G markets. ? Taiwan Semiconductor—Powering the Future of Tech! #TSM #Semiconductors #AI #5G
From the 4-hour analysis, we continue to focus on the 2650-53 line of pressure on the top. The rebound relies on this position to continue to short and follow the trend to fall. We focus on the short-term support of 2625 on the bottom. Before breaking through the 2660 mark in the short term, any rebound is a short-selling opportunity. Maintain the main tone of participating in the trend. Gold operation strategy: 1. Gold 2653-2656 line short, stop loss 2662, target 2625-2630 line, break to see 2612 line;